As expected, the inhibition of BMP signaling with dorsomorphin resulted in significantly reduced osteogenesis in pASCs in OM + BMP-2 after 21 and 28 days compared to the OM + BMP-2 group without inhibition (p ≤ 0.05) (Figure 3A,C). Here, BMP2 is linked to ocular melanoma.